Literature DB >> 30613854

The first Korean case report with scaphocephaly as the initial sign of X-linked hypophosphatemic rickets.

Keun Soo Lee1, Bo Lyun Lee2.   

Abstract

INTRODUCTION: X-linked hypophosphatemic rickets (XLH) can occasionally cause premature fusion of cranial sutures through an increased level of fibroblast growth factor 23 (FGF-23), which leads to the dysregulation of phosphate and vitamin D metabolism. Secondary craniosynostosis has long been considered to present late after XLH has already been diagnosed either clinically or genetically. CASE
PRESENTATION: We present observations of a male infant showing sagittal synostosis as the first sign of XLH. Our patient did not show any other skeletal deformities except macrocephaly with a long head shape. There is a family history of genetically unconfirmed hypophosphatemic rickets in his mother. Direct sequencing by genomic polymerase chain reaction revealed that the patient has a large deletion comprising exons 1-3 of the phosphate regulating endopeptidase homolog X-linked (PHEX) gene.
CONCLUSION: Our observations suggest that craniosynostosis secondary to rickets can develop in early infancy. Careful monitoring of head shape and growth is therefore critical for early detection of craniosynostosis in XLH.

Entities:  

Keywords:  Craniosynostosis; PHEX; X-linked hypophosphatemic rickets

Year:  2019        PMID: 30613854     DOI: 10.1007/s00381-018-04042-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  17 in total

1.  Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets.

Authors:  I A Holm; A E Nelson; B G Robinson; R S Mason; D J Marsh; C T Cowell; T O Carpenter
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

2.  X-linked hypophosphatemic rickets and sagittal craniosynostosis: three patients requiring operative cranial expansion: case series and literature review.

Authors:  Phillip Jaszczuk; Gary F Rogers; Raphael Guzman; Mark R Proctor
Journal:  Childs Nerv Syst       Date:  2015-10-28       Impact factor: 1.475

3.  Clinical and molecular heterogeneity in a large series of patients with hypophosphatemic rickets.

Authors:  Silvia Capelli; Valentina Donghi; Katia Maruca; Giuseppe Vezzoli; Sabrina Corbetta; Maria Luisa Brandi; Stefano Mora; Giovanna Weber
Journal:  Bone       Date:  2015-06-05       Impact factor: 4.398

Review 4.  Evidence-based medicine: Craniosynostosis.

Authors:  Jeffrey A Fearon
Journal:  Plast Reconstr Surg       Date:  2014-05       Impact factor: 4.730

5.  Age at initial consultation for craniosynostosis: comparison across different patient characteristics.

Authors:  Mitchel Seruya; Albert K Oh; Michael J Boyajian; John S Myseros; Amanda L Yaun; Robert F Keating; Gary F Rogers
Journal:  J Craniofac Surg       Date:  2013-01       Impact factor: 1.046

6.  Familial hypophosphatemic rickets caused by a large deletion in PHEX gene.

Authors:  Tasuku Saito; Yutaka Nishii; Toshiyuki Yasuda; Nobuaki Ito; Hisanori Suzuki; Takashi Igarashi; Seiji Fukumoto; Toshiro Fujita
Journal:  Eur J Endocrinol       Date:  2009-07-06       Impact factor: 6.664

Review 7.  X-linked hypophosphatemic rickets and craniosynostosis.

Authors:  Ananth S Murthy
Journal:  J Craniofac Surg       Date:  2009-03       Impact factor: 1.046

8.  Mutational analysis of patients with FGF23-related hypophosphatemic rickets.

Authors:  Yuka Kinoshita; Tasuku Saito; Yuichiro Shimizu; Michiko Hori; Manabu Taguchi; Takashi Igarashi; Seiji Fukumoto; Toshiro Fujita
Journal:  Eur J Endocrinol       Date:  2012-05-10       Impact factor: 6.664

9.  Sagittal synostosis in X-linked hypophosphatemic rickets and related diseases.

Authors:  Guido Currarino
Journal:  Pediatr Radiol       Date:  2007-06-06

10.  PHEX gene mutations and genotype-phenotype analysis of Korean patients with hypophosphatemic rickets.

Authors:  Hae Ryong Song; Joo Won Park; Dae Yeon Cho; Jae Hyuk Yang; Hye Ran Yoon; Sung Chul Jung
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.